Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others.
Thursday, 17 November 2016
Global Hospital Microbiology Testing Market: Rising Need to Manage Infectious Disease to Boost Demand
The global hospital microbiology testing market is estimated to witness significant growth in the coming years due to a rise in the awareness level among patients regarding respiratory infections, inflammatory disorders, or any such chronic problems. The hospital microbiology testing market is studied in a new report by Transparency Market Research (TMR). The report is titled, ‘Hospital Microbiology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.’ Reimbursement policies and favorable economic conditions are expected to drive the market in the forecast period.
The report studies the global hospital microbiology testing market’s historical performance and presents detailed forecasts regarding the market’s development between 2016 and 2024. The competitive landscape, regional segmentation, and key drivers and restraints of the global hospital microbiology testing market are elaborated upon in the report. The study also discusses key trends and opportunities in the market and bases its forecasts on these important factors.
The growing prevalence of infectious diseases, outbreaks of epidemics, and most importantly, growing healthcare expenditure have resulted in a significant growth of the hospital microbiology testing market worldwide. Technological advancements, increasing funding, public-private investments in the field of life science researches, and research grants have resulted in higher efficiency, fueling the adoption of microbiology testing in hospitals. In addition to this, a rise in the awareness among people in developing nations regarding sex-related health issues is also expected to drive the hospital microbiology testing market.
The growing incidence of severe and fatal diseases such as HIV, human papilloma virus (HPV), and Hepatitis B and C is increasing the demand for hospital microbiology testing. Improved hospital infrastructures and adequate management of threats of infectious diseases will also aid the market’s growth in the coming years. Additionally, hospital microbiology testing enables effective communication between the doctor and microbiology laboratory.
The report segments the global hospital microbiology testing market on the basis of geography, disease type, and diagnostic technologies. By diagnostic technology, the market is segmented into differential light scattering, molecular diagnostics, immunoassays, monoclonal antibodies, liposome, flow cytometry, gel micro-droplets, and chromatography. On the basis of disease type, the market is segmented into encephalitis, trichomonas vaginalis, antrax, babesiosis, E. coli, brucella, ebola virus, aids, west nile virus, streptococci, tuberculosis, staphylococcus aureus, gonorrhea, toxoplasmosis, chancroid, chagas disease, syphilis, cyclospora cayetanensis, creutzfeldt-jakob's disease, echovirus, epstein-barr virus, enteroviruses, cytomegalovirus, giardia lamblia, candida, adenovirus, campylobacter, chlamydia, clostridium difficile, blastocystis hominis, coxsackieviruses, and coronaviruses.
Key players profiled in the report include Abbott Diagnostics, bioMerieux, Affymetrix, Ortho-Clinical Diagnostics, Cepheid, Hologic, Roche Diagnostics, Qiagen, Thermo Fischer Scientific, and Siemens.